We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Apellis is exclusively distributing injection kits with ...
More than 100,000 vials have been distributed/administered between real world and clinical trials; since last update, confirmed one additional event of retinal ...
Apellis Pharmaceuticals, a biotech drug company based in Waltham, Mass., recalled more than 61,000 injection needle kits after eight retinal vasculitis cases were reported. The company is pulling 12 ...
As the federal government prepares to make it easier for communities to open safe injection sites, a recovering addict in one of Canada's most prolific drug cities is saluting the move. London is one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results